|  |  | Treatment | ||||||
---|---|---|---|---|---|---|---|---|---|
Visit (week) | Screening | Randomization | 2 | 4 | 8 | 16 | 28 | 40 | 46 |
Valid informed consent gained | √ | √ |  |  |  |  |  |  |  |
Full demographic details | √ |  |  |  |  |  |  |  |  |
Relevant medical history taken | √ | √ |  |  |  |  |  |  |  |
Concomitant medications | √ | √ | √ | √ | √ | √ | √ |  |  |
Anthropometric measurements |  | √ |  |  |  |  |  |  |  |
Blood pressure measurement | √ | √ | √ | √ | √ | √ | √ | √ | √ |
Pulse wave velocity and pulse waveform analysis measurement |  | √ |  |  |  |  |  | √ | √ |
Haematological and full biochemical profile | √ |  | √ |  |  |  |  | √ | √ |
Renal profile |  |  |  | √ | √ | √ | √ |  |  |
Urine albumin:creatinine ratio | √ |  |  |  |  |  |  | √ | √ |
EQ5D-5 L questionnaire |  | √ |  |  |  |  |  | √ |  |
Medication monitoring questionnaire |  | √ | √ | √ | √ | √ | √ | √ | √ |